You are currently viewing a new version of our website. To view the old version click .
Journal of Clinical Medicine
  • Correction
  • Open Access

4 November 2019

Correction: Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587

,
,
,
,
,
and
1
Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Münster, 48149 Münster, Germany
2
Institute of Biostatistics and Clinical Research, University Hospital of Münster, 48149 Münster, Germany
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
This article belongs to the Special Issue Recent Advances and Clinical Outcomes of Kidney Transplantation
The authors wish to make the following corrections to this paper [].
The authors made an error regarding the rejection-free survival curve in Figure 4A. Figure 4 needs to be corrected.
Jcm 08 01870 i001
should be replaced with
Jcm 08 01870 i002
The authors apologize to the readers for any inconvenience caused by these changes. It is important to state that this correction do not affect our study’s results and involve no changes or modifications in the original data supporting our results. The original manuscript will remain online on the article webpage, with reference to this Correction.

Reference

  1. Schütte-Nütgen, K.; Thölking, G.; Steinke, J.; Pavenstädt, H.; Schmidt, R.; Suwelack, B.; Reuter, S. Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587. [Google Scholar] [CrossRef] [PubMed]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.